Lecithin-cholesterol acyltransferase and paraoxonase-1 levels in atherosclerotic cardiovascular disease patients in Nigeria.

Promise C Nwaejigh Maria O Ebesunun Oluwaseye M Oladimeji

Published in: African journal of laboratory medicine (2024)

Plasma LCAT and PON-1 may serve as independent markers or complement other established cardiovascular disease markers to discriminate the risk of ASCVD when it is unclear.

Keyphrases

cardiovascular disease
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
peritoneal dialysis
prognostic factors
cardiovascular risk factors
metabolic syndrome
coronary artery disease
patient reported
low density lipoprotein